Back to Search Start Over

PDB36 LONG-TERM Cost-Effectiveness Analyses of Once-Weekly Semaglutide 1 MG Versus Empagliflozin 25 MG for Treatment of Type 2 Diabetes in Three Countries: Bosnia and Herzegovina, Greece, and Slovenia

Authors :
N. Hallén
S. Liatis
A. Thanopoulou
A. Ogrič Lapajne
I. Ioannidis
D. Djekic
B. Hunt
Source :
Value in Health. 23:S512
Publication Year :
2020
Publisher :
Elsevier BV, 2020.

Details

ISSN :
10983015
Volume :
23
Database :
OpenAIRE
Journal :
Value in Health
Accession number :
edsair.doi...........357dbbaa7885f6bb8ce840a3df1263bf